PRVA 📈 Privia Health - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74276R1023
PRVA: Technology, Tools, Services, Networks, Medical, Care
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Web URL: https://www.priviahealth.com
Additional Sources for PRVA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PRVA Stock Overview
Market Cap in USD | 2,624m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2021-04-28 |
PRVA Stock Ratings
Growth 5y | -29.3% |
Fundamental | 26.7% |
Dividend | - |
Rel. Strength Industry | -743 |
Analysts | 4.57/5 |
Fair Price Momentum | 18.48 USD |
Fair Price DCF | 21.94 USD |
PRVA Dividends
No Dividends PaidPRVA Growth Ratios
Growth Correlation 3m | 73.6% |
Growth Correlation 12m | -18.3% |
Growth Correlation 5y | -71.2% |
CAGR 5y | -3.65% |
CAGR/Mean DD 5y | -0.08 |
Sharpe Ratio 12m | -0.27 |
Alpha | -36.25 |
Beta | 0.76 |
Volatility | 53.99% |
Current Volume | 2385.4k |
Average Volume 20d | 655.3k |
What is the price of PRVA stocks?
As of December 22, 2024, the stock is trading at USD 20.07 with a total of 2,385,377 shares traded.
Over the past week, the price has changed by -3.68%, over one month by -4.64%, over three months by +3.55% and over the past year by -14.99%.
As of December 22, 2024, the stock is trading at USD 20.07 with a total of 2,385,377 shares traded.
Over the past week, the price has changed by -3.68%, over one month by -4.64%, over three months by +3.55% and over the past year by -14.99%.
Is Privia Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Privia Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.70 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRVA as of December 2024 is 18.48. This means that PRVA is currently overvalued and has a potential downside of -7.92%.
Neither. Based on ValueRay Fundamental Analyses, Privia Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.70 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRVA as of December 2024 is 18.48. This means that PRVA is currently overvalued and has a potential downside of -7.92%.
Is PRVA a buy, sell or hold?
Privia Health has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy PRVA.
Privia Health has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy PRVA.
- Strong Buy: 14
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for PRVA stock price target?
According to ValueRays Forecast Model, PRVA Privia Health will be worth about 20.4 in December 2025. The stock is currently trading at 20.07. This means that the stock has a potential upside of +1.59%.
According to ValueRays Forecast Model, PRVA Privia Health will be worth about 20.4 in December 2025. The stock is currently trading at 20.07. This means that the stock has a potential upside of +1.59%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 26.2 | 30.5% |
Analysts Target Price | 37.1 | 84.8% |
ValueRay Target Price | 20.4 | 1.6% |